STAAR Surgical launches $50 million share buyback program
STAA•STAAR Surgical authorized up to $50 million in common-stock repurchases over the next 12 months, subject to market conditions. The company reported $181.5 million in cash, equivalents and available-for-sale investments as of July 3, 2026, and no outstanding debt.
1. Repurchase program
STAAR Surgical launched a share repurchase program authorizing up to $50 million in common-stock buybacks. Repurchases may take place over the next 12 months, subject to market conditions, and the company can change or halt the program at any time.
2. Funding and shares
STAAR plans to fund repurchases with free cash flow and cash on hand. It reported $181.5 million in cash, equivalents and available-for-sale investments as of July 3, 2026, no outstanding debt, and 50,100,000 common shares outstanding as of August 7, 2026.
